Cutting edge: Receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells

Journal of Immunology

Volumn 190, Issue 12, 2013, Pages 5921-5925

  Van Der Touw, William ^a   Cravedi, Paolo ^a   Kwan, Wing Hong ^a   Paz Artal, Estela ^a   Merad, Miriam ^a   Heeger, Peter S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ALLOANTIGEN; COMPLEMENT COMPONENT C3A RECEPTOR; COMPLEMENT COMPONENT C5 INHIBITOR; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT INHIBITOR; COMPLEMENT RECEPTOR; GAMMA INTERFERON; SB 290157; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ADAPTIVE IMMUNITY; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMBINATION CHEMOTHERAPY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DRUG POTENTIATION; EFFECTOR CELL; GENE SILENCING; GENETIC DISORDER; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSTIMULATION; INTRACELLULAR SIGNALING; MOLECULAR STABILITY; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN TARGETING; REGULATORY T LYMPHOCYTE; TH1 CELL;

ANIMALS; COMPLEMENT C3A; FLOW CYTOMETRY; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOBLOTTING; ISOANTIGENS; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; RECEPTOR, ANAPHYLATOXIN C5A; SELF TOLERANCE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84879087114     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300847     Document Type: Article

References (26)

1. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133: 775-787. (Pubitemid 351707693)
2. H2 inflammation. Nature 482: 395-399.
3. Roncarolo, M. G., and M. Battaglia. 2007. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol. 7: 585-598. (Pubitemid 47123554)
4. + regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 196: 389-399.
5. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99: 3493-3499.
6. + immunoregulatory T cells: new therapeutics for graft-versus-host disease. J. Exp. Med. 196: 401-406.
7. Rubtsov, Y. P., R. E. Niec, S. Josefowicz, L. Li, J. Darce, D. Mathis, C. Benoist, and A. Y. Rudensky. 2010. Stability of the regulatory T cell lineage in vivo. Science 329: 1667-1671.
8. Zhou, X., S. L. Bailey-Bucktrout, L. T. Jeker, C. Penaranda, M. Martínez-Llordella, M. Ashby, M. Nakayama, W. Rosenthal, and J. A. Bluestone. 2009. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10: 1000-1007.
9. + T cells. Immunity 28: 425-435.
10. Kwan, W. H., W. van der Touw, E. Paz-Artal, M. O. Li, and P. S. Heeger. 2013. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J. Exp. Med. 210: 257-268.
11. Kwan, W. H., D. Hashimoto, E. Paz-Artal, K. Ostrow, M. Greter, H. Raedler, M. E. Medof, M. Merad, and P. S. Heeger. 2012. Antigen-presenting cell-derived complement modulates graft-versus-host disease. J. Clin. Invest. 122: 2234-2238.
12. Lalli, P. N., M. G. Strainic, M. Yang, F. Lin, M. E. Medof, and P. S. Heeger. 2008. Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood 112: 1759-1766.
13. + cells. J. Exp. Med. 205: 565-574.
14. Kerdiles, Y. M., E. L. Stone, D. R. Beisner, M. A. McGargill, I. L. Ch'en, C. Stockmann, C. D. Katayama, and S. M. Hedrick. 2010. Foxo transcription factors control regulatory T cell development and function. Immunity 33: 890-904.
15. Floess, S., J. Freyer, C. Siewert, U. Baron, S. Olek, J. Polansky, K. Schlawe, H. D. Chang, T. Bopp, E. Schmitt, et al. 2007. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5: e38.
16. Zheng, Y., S. Josefowicz, A. Chaudhry, X. P. Peng, K. Forbush, and A. Y. Rudensky. 2010. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463: 808-812.
17. Sela, U., P. Olds, A. Park, S. J. Schlesinger, and R. M. Steinman. 2011. Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice. J. Exp. Med. 208: 2489-2496.
18. Ito, R., I. Katano, K. Kawai, H. Hirata, T. Ogura, T. Kamisako, T. Eto, and M. Ito. 2009. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice. Transplantation 87: 1654-1658.
19. Lynch, D. M., and P. H. Kay. 1995. Studies on the polymorphism of the fifth component of complement in laboratory mice. Exp. Clin. Immunogenet. 12: 253-260. (Pubitemid 26047636)
20. Bao, L., I. Osawe, T. Puri, J. D. Lambris, M. Haas, and R. J. Quigg. 2005. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur. J. Immunol. 35: 2496-2506. (Pubitemid 41179771)
21. Guinan, E. C., V. A. Boussiotis, D. Neuberg, L. L. Brennan, N. Hirano, L. M. Nadler, and J. G. Gribben. 1999. Transplantation of anergic histoincompatible bone marrow allografts. N. Engl. J. Med. 340: 1704-1714. (Pubitemid 29252598)
22. Wallace, P. M., J. S. Johnson, J. F. MacMaster, K. A. Kennedy, P. Gladstone, and P. S. Linsley. 1994. CTLA4Ig treatment ameliorates the lethality of murine graft-versus-host disease across major histocompatibility complex barriers. Transplantation 58: 602-610. (Pubitemid 24289853)
23. Lee, R. S., J. R. Rusche, M. E. Maloney, D. H. Sachs, M. H. Sayegh, and J. C. Madsen. 2001. CTLA4Ig-induced linked regulation of allogeneic T cell responses. J. Immunol. 166: 1572-1582. (Pubitemid 32114637)
24. Charbonnier, L. M., B. Vokaer, P. H. Lemaître, K. A. Field, O. Leo, and A. Le Moine. 2012. CTLA4-Ig restores rejection of MHC class-II mismatched allografts by disabling IL-2-expanded regulatory T cells. Am. J. Transplant. 12: 2313-2321.
25. Riella, L. V., T. Liu, J. Yang, S. Chock, T. Shimizu, B. Mfarrej, I. Batal, X. Xiao, M. H. Sayegh, and A. Chandraker. 2012. Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model. Am. J. Transplant. 12: 846-855.
26. + regulatory T cells. Nat. Immunol. 14: 162-171.